BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11147220)

  • 21. The role of cytology, cytochemistry, immunophenotyping and cytogenetic analysis in the diagnosis of haematological neoplasms. General Haematology Task Force of the BCSH.
    Clin Lab Haematol; 1996 Dec; 18(4):231-6. PubMed ID: 9054693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic changes: relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia.
    Cole-Sinclair MF; Foroni L; Hoffbrand AV
    Baillieres Clin Haematol; 1994 Jun; 7(2):183-233. PubMed ID: 7803899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic classification of acute lymphoblastic leukemia.
    Cabrera ME
    Am J Pediatr Hematol Oncol; 1990; 12(3):283-91. PubMed ID: 2240474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifaceted approach to the diagnosis and classification of acute leukemias.
    McKenna RW
    Clin Chem; 2000 Aug; 46(8 Pt 2):1252-9. PubMed ID: 10926919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostics of acute leukemias: interaction of phenotypic and genetic methods].
    Bacher U; Haferlach C; Schnittger S; Kern W; Ott MM; Haferlach T
    Pathologe; 2012 Nov; 33(6):528-38. PubMed ID: 23085696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the diagnostic approach to childhood lymphoblastic malignant neoplasms.
    Reddy KS; Perkins SL
    Am J Clin Pathol; 2004 Dec; 122 Suppl():S3-18. PubMed ID: 15690639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
    Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
    Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification.
    De Zen L; Orfao A; Cazzaniga G; Masiero L; Cocito MG; Spinelli M; Rivolta A; Biondi A; Zanesco L; Basso G
    Leukemia; 2000 Jul; 14(7):1225-31. PubMed ID: 10914546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias".
    Invernizzi R; Rosanda C; Basso G; Conter V; di Cataldo A; Fenu S; Forni M; Frappampina V; Granchi D; Locatelli F
    Haematologica; 1992; 77(1):30-4. PubMed ID: 1383101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometry with or without cytochemistry for the diagnosis of acute leukemias?
    Kheiri SA; MacKerrell T; Bonagura VR; Fuchs A; Billett HH
    Cytometry; 1998 Apr; 34(2):82-6. PubMed ID: 9579605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO).
    Iwata H; Kami M; Kishi Y; Oki Y; Tanaka Y; Takeuchi K; Yamazaki I; Suzuki R; Morinaga S; Mutou Y
    Leukemia; 2000 Nov; 14(11):2013-4. PubMed ID: 11069040
    [No Abstract]   [Full Text] [Related]  

  • 34. Variable manifestation in natural killer cell leukaemia.
    Kuroda J; Kimura S; Kobayashi Y; Jyoko N; Kamitsuji Y; Murotani Y; Fukuda W; Akaogi T; Hayashi H; Yoshikawa T; Maekawa T
    Clin Lab Haematol; 2003 Aug; 25(4):239-45. PubMed ID: 12890163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.
    van Lochem EG; Wiegers YM; van den Beemd R; Hählen K; van Dongen JJ; Hooijkaas H
    Leukemia; 2000 Apr; 14(4):688-95. PubMed ID: 10764156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
    Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
    Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach.
    Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
    Ann Hematol; 2007 May; 86(5):311-27. PubMed ID: 17375301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD34, FasR, Bcl-2, apoptotic index and DNA index in acute lymphoblastic leukaemia in adults.
    Pietruczuk M; Dabrowska M; Osada J; Kostecka I; Suchowierska M; Kłoczko J
    Leuk Lymphoma; 2003 Mar; 44(3):553-6. PubMed ID: 12688333
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome.
    Thomas X; Vila L; Campos L; Sabido O; Archimbaud E
    Leuk Lymphoma; 1995 Oct; 19(3-4):295-300. PubMed ID: 8535222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.